PROGNOSTIC SIGNIFICANCE RBC TRANSFUSIONS' VOLUME INFUSED DURING THE FIRST INDUCTION CHEMOTHERAPY TO PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA (AML)

被引:0
作者
Davaasambuu, B. [1 ]
Gritsaev, S. [1 ]
机构
[1] Russian Inst Hematol & Transfusiol, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B1304
引用
收藏
页码:533 / 533
页数:1
相关论文
共 50 条
  • [31] Complex Karyotype has Adverse Prognostic Impact in Pediatric De Novo Acute Myeloid Leukemia (AML)
    Kim, S.
    Lee, J. W.
    Jang, P. S.
    Chung, N. G.
    Cho, B.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S181 - S181
  • [32] Prognostic significance of dysplastic hematopoiesis in patients with de novo AML
    Florschutz, A
    Kahl, C
    Borstel, A
    Grabenhorst, U
    Hoffkes, HG
    Franke, A
    BLOOD, 1996, 88 (10) : 313 - 313
  • [33] XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients
    El-Tokhy, Mervat A.
    Hussein, Neveen A.
    Bedewy, Ahmed M. L.
    Barakat, Mohammad R.
    HEMATOLOGY, 2014, 19 (07) : 397 - 403
  • [34] PROGNOSTIC-SIGNIFICANCE OF KARYOTYPE IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA
    DASTUGUE, N
    PAYEN, C
    LAFAGEPOCHITALOFF, M
    BERNARD, P
    LEROUX, D
    HUGUETRIGAL, F
    STOPPA, AM
    MARIT, G
    MOLINA, L
    MICHALLET, M
    MARANINCHI, D
    ATTAL, M
    REIFFERS, J
    LEUKEMIA, 1995, 9 (09) : 1491 - 1498
  • [35] Severity of and contributors to distress in patients with acute myeloid leukemia (AML) receiving induction chemotherapy
    LeBlanc, Thomas William
    Wolf, Steven Paul
    Davis, Debra M.
    Samsa, Greg
    Locke, Susan C.
    El-Jawahri, Areej
    Tulsky, James A.
    Abernethy, Amy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [36] Integrating resistance functions to predict response to induction chemotherapy in de novo acute myeloid leukemia
    Chiu, Yu-Chiao
    Hsiao, Tzu-Hung
    Tsai, Jia-Rong
    Wang, Li-Ju
    Ho, Tzu-Chieh
    Hsu, Shih-Lan
    Teng, Chieh-Lin Jerry
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 417 - 425
  • [38] Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia
    Li, You-Cheng
    Shih, Yu-Hsuan
    Chen, Tsung-Chih
    Gau, Jyh-Pyng
    Su, Yu-Chen
    Chen, Mei-Hui
    Hsu, Chiann-Yi
    Liao, Cai-Sian
    Teng, Chieh-Lin Jerry
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [39] Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia:: a study from the Acute Leukemia French Association (ALFA)
    Preudhomme, C
    Sagot, C
    Boissel, N
    Cayuela, JM
    Tigaud, I
    de Botton, S
    Thomas, X
    Raffoux, E
    Lamandin, C
    Castaigne, S
    Fenaux, P
    Dombret, H
    BLOOD, 2002, 100 (08) : 2717 - 2723
  • [40] The prognostic factors and efficacy of induction chemotherapy in elderly patients with acute myeloid leukemia
    Mao, Jianping
    Gao, Wenliang
    Xue, Lianguo
    Zhao, Lidong
    Miao, Lei
    Jia, Tao
    Zhu, Yuanxin
    Wang, Ying
    Meng, Lijuan
    Wang, Juan
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2020, 10 (06): : 320 - 329